Euclidean Capital as of June 30, 2021
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 14 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pmv Pharmaceuticals (PMVP) | 43.3 | $134M | 3.9M | 34.16 | |
| Ngm Biopharmaceuticals | 9.6 | $29M | 1.5M | 19.72 | |
| Denali Therapeutics (DNLI) | 8.2 | $25M | 324k | 78.44 | |
| Rapt Therapeutics | 7.6 | $23M | 736k | 31.79 | |
| Alector (ALEC) | 6.6 | $20M | 981k | 20.83 | |
| Constellation Pharmceticls I | 6.1 | $19M | 554k | 33.80 | |
| Oric Pharmaceuticals (ORIC) | 5.7 | $18M | 997k | 17.69 | |
| Foghorn Therapeutics (FHTX) | 4.4 | $14M | 1.3M | 10.67 | |
| Snowflake Cl A (SNOW) | 3.7 | $11M | 47k | 241.79 | |
| First Financial Ban (FFBC) | 1.3 | $4.1M | 174k | 23.63 | |
| Nurix Therapeutics (NRIX) | 1.3 | $4.1M | 154k | 26.53 | |
| Beam Therapeutics (BEAM) | 1.3 | $4.0M | 31k | 128.71 | |
| Pinduoduo Sponsored Ads (PDD) | 0.4 | $1.2M | 9.8k | 127.07 | |
| Vir Biotechnology (VIR) | 0.4 | $1.2M | 26k | 47.28 |
